Horst R L, Littledike E T, Gray R W, Napoli J L
J Clin Invest. 1981 Jan;67(1):274-80. doi: 10.1172/JCI110023.
Plasma 25-hydroxyvitamin D and 24, 25-dihydroxy-vitamin D [24,25-(OH)(2)D] concentrations were measured in normal and chronically dialyzed anephric humans and pigs. Measurement of the 24, 25-(OH)(2)D was preceded by three purification steps involving one Sephadex LH-20 column and two high-pressure liquid chromatographic columns. The final high-pressure liquid chromatography step involved resolution of 25-hydroxy-vitamin D(3)-26,23 lactone and 25,26-dihydroxy-vitamin D(2) from 24,25-dihydroxyvitamin D(2) and 24,25-dihydroxyvitamin D(3) [24,25-(OH)(2)D(3)]. The total 25-hydroxyvitamin D [25-hydroxyvitamin D(2) plus 25-hydroxyvitamin D(3) (25-OHD(3))] was 31.7+/-3.6 ng/ml in the plasma of eight anephric human subjects and 40.1+/-3.7 ng/ml in five normal human subjects. Six of the eight anephric patients had undetectable (<0.2 ng/ml) 24,25-(OH)(2)D concentrations. Two of the eight patients had very low (0.51 and 0.41 ng/ml), but detectable, 24,25-dihydroxyvitamin D(2). The normal human volunteers had plasma 24,25-(OH)(2)D concentrations of 2.8+/-0.7 ng/ml. Chronically dialyzed anephric and normal pigs were given intramuscular injections of massive amounts (5 x 10(6) IU) of vitamin D(3) immediately after surgery (day 0) and again on day 7. In anephric pigs, plasma 25-OHD(3) progressively rose from 12+/-4 ng/ml on day 0 to 705+/-62 ng/ml on day 10. The 25-OHD(3) concentrations in normal pigs rose from 8+/-2 ng/ml on day 0 to 439+/-64 ng/ml on day 10. Plasma 25-OHD(3) was higher in anephrics throughout the experiment, and concentrations were significantly higher (P < 0.05) on days 9 and 10. Plasma 24,25-(OH)(2)D(3) concentrations declined progressively in anephric pigs from 3.6+/-0.6 ng/ml on day 0 to 3.2+/-0.7 ng/ml on day 2. During days 4-10, plasma 24,25-(OH)(2)D(3) was not apparent until plasma 25-OHD(3) was >400 ng/ml. In control pigs, plasma 24,25-(OH)(2)D(3) was elevated from 4.3+/-0.6 ng/ml on day 0 to 178+/-2.7 ng/ml on day 3. Plasma 24,25-(OH)(2)D(3) was significantly higher (P < 0.05) in controls on days 1-8. At the end of the experiment (day 10), 24,25-(OH)(2)D(3) concentrations were similar and not significantly different in both groups (87.0+/-18.4 ng/ml in anephric and 110.3+/-32.1 ng/ml in normal pigs). The identity of the 24,25-(OH)(2)D(3) isolated from anephric pig plasma was confirmed by mass spectroscopy. Our data suggest that anephric humans receiving normal dietary levels of vitamin D(3) have little or no ability to produce 24,25-(OH)(2)D. However, we have shown that pigs produce 24,25-(OH)(2)D(3) when plasma 25-OHD(3) is extremely high (>400 ng/ml).
我们检测了正常人和长期接受透析的无肾人类及猪的血浆25-羟基维生素D和24,25-二羟基维生素D [24,25-(OH)(2)D] 浓度。在测定24,25-(OH)(2)D之前,进行了三个纯化步骤,包括一个葡聚糖凝胶LH-20柱和两个高压液相色谱柱。最后一个高压液相色谱步骤涉及从24,25-二羟基维生素D(2)和24,25-二羟基维生素D(3) [24,25-(OH)(2)D(3)] 中分离出25-羟基维生素D(3)-26,23内酯和25,26-二羟基维生素D(2)。八名无肾人类受试者血浆中的总25-羟基维生素D [25-羟基维生素D(2)加25-羟基维生素D(3) (25-OHD(3))] 为31.7±3.6 ng/ml,五名正常人类受试者为40.1±3.7 ng/ml。八名无肾患者中有六名的24,25-(OH)(2)D浓度检测不到 (<0.2 ng/ml)。八名患者中有两名的24,25-二羟基维生素D(2) 浓度非常低 (0.51和0.41 ng/ml),但可检测到。正常人类志愿者的血浆24,25-(OH)(2)D浓度为2.8±0.7 ng/ml。长期接受透析的无肾猪和正常猪在手术后立即 (第0天) 以及第7天接受了大量 (5×10(6) IU) 的维生素D(3) 肌肉注射。在无肾猪中,血浆25-OHD(3) 从第0天的12±4 ng/ml逐渐升至第10天的705±62 ng/ml。正常猪的25-OHD(3) 浓度从第0天的8±2 ng/ml升至第10天的439±64 ng/ml。在整个实验过程中,无肾猪的血浆25-OHD(3) 较高,在第9天和第10天浓度显著更高 (P < 0.05)。无肾猪血浆24,25-(OH)(2)D(3) 浓度从第0天的3.6±0.6 ng/ml逐渐降至第2天的3.2±0.7 ng/ml。在第4 - 10天,直到血浆25-OHD(3) >400 ng/ml时,血浆24,25-(OH)(2)D(3) 才出现。在对照猪中,血浆24,25-(OH)(2)D(3) 从第0天的4.3±0.6 ng/ml升至第3天的178±2.7 ng/ml。在第1 - 8天,对照组的血浆24,25-(OH)(2)D(3) 显著更高 (P < 0.05)。在实验结束时 (第10天),两组的24,25-(OH)(2)D(3) 浓度相似且无显著差异 (无肾猪为87.0±18.4 ng/ml,正常猪为110.3±32.1 ng/ml)。通过质谱法确认了从无肾猪血浆中分离出的24,25-(OH)(2)D(3) 的同一性。我们的数据表明,摄入正常饮食水平维生素D(3) 的无肾人类几乎没有或没有产生24,25-(OH)(2)D的能力。然而,我们已经表明,当血浆25-OHD(3) 极高 (>400 ng/ml) 时,猪会产生24,25-(OH)(2)D(3)。